Riverwater Partners’s AbbVie ABBV Stock Holding History

Riverwater Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$261K	Buy	+1,039	New	+$224K	0.08%	189
2025 Q4	–	Sell	-1,333	Closed	-$309K	–	213
2025 Q3	$309K	Buy	+1,333	New	+$271K	0.13%	180
2024 Q1	–	Sell	-1,714	Closed	-$266K	–	188
2023 Q4	$266K	Sell	1,714 -435	-20%	-$63.4K	0.21%	157
2023 Q3	$320K	Buy	2,149 +478	+29%	+$70.2K	0.29%	120
2023 Q2	$225K	Hold	1,671	–	–	0.2%	163
2023 Q1	$266K	Sell	1,671 -365	-18%	-$55.8K	0.24%	138
2022 Q4	$329K	Sell	2,036 -3	-0.1%	-$460	0.28%	110
2022 Q3	$274K	Sell	2,039 -69	-3%	-$9.9K	0.27%	120
2022 Q2	$323K	Buy	+2,108	New	+$322K	0.33%	109
2022 Q1	–	Sell	-2,681	Closed	-$363K	–	104
2021 Q4	$363K	Buy	+2,681	New	+$317K	0.32%	111

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Riverwater Partners's ABBV Position: Q2 2026 in Review

Riverwater Partners opened a new position in AbbVie (ABBV) in Q2 2026: 1,039 shares worth $261K. The stake represents 0.08% of the portfolio and ranks #189 among its holdings. This is a return to the name: Riverwater Partners previously reported a position in ABBV as recently as Q3 2025.

Riverwater Partners first reported a position in ABBV in Q4 2021 and has held it in 10 quarters since. The position peaked at $363K in Q4 2021. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Riverwater Partners held 1,039 shares of AbbVie worth $261K as of Q2 2026.
AbbVie was a new Riverwater Partners position in Q2 2026.
AbbVie made up 0.08% of Riverwater Partners's portfolio in Q2 2026, its #189 holding.
Riverwater Partners first reported a position in AbbVie in Q4 2021 and has held it in 10 quarters since.
Riverwater Partners's AbbVie position peaked at $363K in Q4 2021.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.